Muntinlupa LGU launches vaccination registration for 5 to 11 years old

Published January 6, 2022, 10:33 AM

by Jonathan Hicap

The Muntinlupa City government launched the registration for COVID-19 vaccination of minors aged 5 to 11 years old.

Included in the registration are 5-to-11-year-olds with and without comorbidities. The registration was launched to make a master list of kids for vaccination while the city government is awaiting final guidelines from the Department of Health (DOH).

Vaccination in Muntinlupa (Muntinlupa PIO)

According to the Muntinlupa City Health Office (CHO), a total of 260 minors aged 5 to 11 have registered for vaccination to date.

Former Food and Drug Administration Director General Eric Domingo announced last Dec. 23 that the agency approved the Emergency Use Authorization (EUA) for the Pfizer-BioNTech vaccine to be used for 5 to 11-year-olds.

He said the National Task Force Against COVID-19 (NTF) and the Department of Health (DOH) were planning to roll out the vaccination of 5 to 11-year-olds as early as January but it would depend on the supply.

“It will depend if they have already ordered or if they have already secured [supply], already bought supplies for the vaccine for children and if they are ready to roll out. The plan is really as early as January,” he said.

According to Domingo, Pfizer applied for the EUA for 5 to 11 years old at the end of November, saying, “This vaccine is already being used in children in many countries such as the US, in Europe and in Canada and upon the review of the technical documents and the evaluation of the US FDA recommendations, our experts have found that data submitted is sufficient for the EUA approval.”

“It is reasonable to believe that the vaccine may be effective to prevent COVID-19 and the benefits of vaccination outweigh the known and potential risks.”

The dosage that will be administered to minors aged 5 to 11 years old will be lower than those given to adults and 12 to 17 years old.

To register in Muntinlupa, go to and choose the following:

• “Pediatric A3 (5-11 yrs. old)” – with comorbidities

• “Pediatric/Rest of the Pediatric Population (5-11 yrs. old)” – without comorbidities